Literature DB >> 11800470

Linkage between toxin production and purine biosynthesis in Clostridium difficile.

Tsuneo Maegawa, Tadahiro Karasawa, Toshiko Ohta1, Xingmin Wang, Haru Kato, Hideo Hayashi1, Shinichi Nakamura.   

Abstract

The production of toxins A and B by Clostridium difficile was greatly enhanced under biotin-limited conditions, in which a 140-kDa protein was expressed strongly. Gene cloning revealed that this protein was a homologue of formylglycinamidine ribonucleotide synthetase (FGAM synthetase, EC 6.3.5.3), which is known as PurL in Escherichia coli and catalyses the fourth step of the de novo purine biosynthesis pathway. This enzyme consisted of a single polypeptide, although FGAM synthetases of gram-positive bacteria usually consist of two subunits. Inhibition of the enzymic activity of C. difficile PurL by O-diazoacetyl-L-serine (azaserine) resulted in enhanced toxin B production even in biotin-sufficient conditions. In contrast, blockade of the preceding step of the PurL catalysing step by sulfamethoxazole inhibited toxin B production almost completely. These results suggest that accumulation of formylglycinamide ribonucleotide (FGAR), a substrate of FGAM synthetase, enhances toxin production by C difficile and depletion of FGAR reduces toxin production.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11800470     DOI: 10.1099/0022-1317-51-1-34

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

Review 1.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Genetic requirements for potassium ion-dependent colony spreading in Bacillus subtilis.

Authors:  Rebecca F Kinsinger; Daniel B Kearns; Marina Hale; Ray Fall
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

3.  Analysis of proline reduction in the nosocomial pathogen Clostridium difficile.

Authors:  Sarah Jackson; Mary Calos; Andrew Myers; William T Self
Journal:  J Bacteriol       Date:  2006-10-13       Impact factor: 3.490

4.  Expression of Clostridium difficile toxins A and B and their sigma factor TcdD is controlled by temperature.

Authors:  Sture Karlsson; Bruno Dupuy; Kakoli Mukherjee; Elisabeth Norin; Lars G Burman; Thomas Akerlund
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

5.  Using phenotype microarrays to determine culture conditions that induce or repress toxin production by Clostridium difficile and other microorganisms.

Authors:  Xiang-He Lei; Barry R Bochner
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

6.  Differential stress transcriptome landscape of historic and recently emerged hypervirulent strains of Clostridium difficile strains determined using RNA-seq.

Authors:  Joy Scaria; Chunhong Mao; Jenn-Wei Chen; Sean P McDonough; Bruno Sobral; Yung-Fu Chang
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

7.  Importance of Glutamate Dehydrogenase (GDH) in Clostridium difficile Colonization In Vivo.

Authors:  Brintha Parasumanna Girinathan; Sterling Braun; Apoorva Reddy Sirigireddy; Jose Espinola Lopez; Revathi Govind
Journal:  PLoS One       Date:  2016-07-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.